NASDAQ: NVAX · Health Care / Biotechnology: Biological Products (No Diagnostic Substances)

Novavax Inc.

How Novavax Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$1.7B

Price

$10.47

P/E

-7.0

EPS (TTM)

$-1.50

1-year return

24.9%

Dividend yield

0.0%

52-week range

$6.22–$12.82

Compared with

• Biotechnology: Biological Products (No Diagnostic Substances) industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources